Unknown

Dataset Information

0

4-1BB (CD137) in anticancer chimeras.

ABSTRACT: 4-1BB (CD137, TNFRSF9) mediates costimulatory signals important for activation and persistence of cytotoxic T lymphocytes. In this issue of JEM, Oda et al. (https://doi.org/10.1084/jem.20191166) report on a chimeric construction encompassing extracellular Fas and intracellular 4-1BB to dramatically improve adoptive T cell therapy.

SUBMITTER: Melero I 

PROVIDER: S-EPMC7549314 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Functional expression of CD137 (4-1BB) on T helper follicular cells.
| S-EPMC4635945 | biostudies-literature
Unknown New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axis.
| S-EPMC7333812 | biostudies-literature
Unknown Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4-1BB).
| S-EPMC5739564 | biostudies-literature
Transcriptomics Effect of CD137 (4-1BB) triggering on human monocytes
2021-06-17 | GSE171108 | GEO
Unknown PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics.
| S-EPMC7319888 | biostudies-literature
Unknown Anticancer immunity induced by a synthetic tumor-targeted CD137 agonist.
| S-EPMC7839861 | biostudies-literature
Unknown A mathematical model of combined CD8 T cell costimulation by 4-1BB (CD137) and OX40 (CD134) receptors.
| S-EPMC6659676 | biostudies-literature
Unknown CD73 expression on effector T cells sustained by TGF-? facilitates tumor resistance to anti-4-1BB/CD137 therapy.
| S-EPMC6329764 | biostudies-literature
Unknown CD137 (4-1BB) stimulation leads to metabolic and functional reprogramming of human monocytes/macrophages enhancing their tumoricidal activity.
| S-EPMC8632678 | biostudies-literature
Genomics Effect of CD137 (4-1BB) triggering on human monocytes
| PRJNA718345 | ENA